Evidence map›Paper›PMID 32429325›Full record

ReviewGenes2020

Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability.

Giorgio Milazzo, Daniele Mercatelli, Giulia Di Muzio, Luca Triboli, Piergiuseppe De Rosa, Giovanni Perini, Federico M Giorgi

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 243 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
243citing papers in PubMed, 2 pooled it
14.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

243 citing papers in PubMed, 2 syntheses or guidelines pooled it, 385 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Special Issue "Epigenetic Genes, Biomarkers and Immunotherapy in Cancers".International journal of molecular sciences · 2026
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

183 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Giorgio MilazzoDepartment of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 41026 Bologna, Italy.
Daniele MercatelliDepartment of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 41026 Bologna, Italy.ORCID 0000-0003-3228-0580
Giulia Di MuzioDepartment of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 41026 Bologna, Italy.
Luca TriboliDepartment of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 41026 Bologna, Italy.
Piergiuseppe De RosaDepartment of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 41026 Bologna, Italy.
Giovanni PeriniDepartment of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 41026 Bologna, Italy.
Federico M GiorgiDepartment of Pharmacy and Biotechnology, University of Bologna, Via Selmi 3, 41026 Bologna, Italy.ORCID 0000-0002-7325-9908
University of Bologna · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Histone deacetylases (HDACs) are evolutionary conserved enzymes which operate by removing acetyl groups from histones and other protein regulatory factors, with functional consequences on chromatin remodeling and gene expression profiles. We provide here a review on the recent knowledge accrued on the zinc-dependent HDAC protein family across different species, tissues, and human pathologies, specifically focusing on the role of HDAC inhibitors as anti-cancer agents. We will investigate the chemical specificity of different HDACs and discuss their role in the human interactome as members of chromatin-binding and regulatory complexes.

Indexed as

Antineoplastic AgentsHistone Deacetylase InhibitorsHistone DeacetylasesHistonesHumansNeoplasmsSubstrate SpecificityTranscription FactorsAntineoplastic AgentsHistone Deacetylase InhibitorsHistone DeacetylasesHistonesTranscription Factorscancerchromatinepigeneticsepigenomicsgene networksHDACHDACiHDAC inhibitorshistone deacetylasesphylogenesis

Identifiers

PMID32429325
PMCPMC7288346
OpenAlexW3024404242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.